Skip to Content

    Funded Studies Details

    Funded Studies Details

    << Back

     

    2022 Pilot Awards for Global Brain Health Leaders (GBHI)

    Preferences for Everyday Living Inventory-Korean (PELI-K)

    How can we assess the needs and preferences of individuals with Alzheimer’s in Korea?

    So Young Shin, Ph.D.
    Inje University
    Gimhae, United States



    Background

    Caregivers of individuals with dementia are often required to have a thorough understanding of their care recipient’s needs and preferences for disease management. However, standardized questionnaires and other tools to assess the preferences and needs of individuals with dementia often do not consider the cultural and language needs of underrepresented populations. Dr. So Young Shin proposes a pilot study that will translate a commonly used needs assessment tool, called the Preferences for Everyday Living Inventory (PELI) into Korean with the aim of creating a culturally appropriate and validated method for assessing needs of individuals with dementia in Korea.

    Research Plan

    Dr. Shin and colleagues plan to first translate the PELI assessment tool into Korean and culturally modify the assessment as needed. They will then administer the assessment to 10 cognitively unimpaired individuals to ensure the assessment is understandable and culturally appropriate for Korean-speaking individuals. Next, the team will recruit 30 individuals with dementia living in long-term care facilities in Busan, South Korea to validate the assessment tool in a range of individuals.

    Impact

    This study could provide valuable insights into how well everyday needs and preferences for individuals with dementia in Korea are being assessed. It may also develop a novel, more culturally appropriate assessment for older persons with dementia in Korea.

    The first survivor of Alzheimer's is out there, but we won't get there without you.

    Donate Now

    Learn how Alzheimer’s disease affects the brain.

    Take the Brain Tour

    Don't just hope for a cure. Help us find one.

    Learn More